Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
Homerun Resources Inc. Receives Joint Support Plan from BNDES and FINEP Indicating Financial Instruments Available to Support Homerun's Business Plan